Studies Highlight Unmet Needs and Cost-Effectiveness of SSO2 Therapy for Severe Heart Attack Patients

ZOLL®, an Asahi Kasei company specializing in medical devices and software solutions, has announced the results of two significant studies on the economic burden of heart failure resulting from severe heart attacks and the long-term cost-effectiveness of SuperSaturated Oxygen (SSO2)…

Read MoreStudies Highlight Unmet Needs and Cost-Effectiveness of SSO2 Therapy for Severe Heart Attack Patients

IKS Health Partners with Radiology Partners to Enhance Services with Care Enablement Platform

IKS Health, a provider of healthcare enablement solutions, has partnered with Radiology Partners (RP), a leading U.S. radiology practice. This collaboration utilizes IKS Health’s Gen AI-powered Care Enablement Platform to streamline processes and enhance access to essential imaging services. The…

Read MoreIKS Health Partners with Radiology Partners to Enhance Services with Care Enablement Platform

Relief Mental Health Expands to Middleton, WI, Offering Advanced Treatments in the Madison Area

Relief Mental Health, a leader in innovative mental health care, is thrilled to announce the opening of its 11th outpatient clinic in Middleton, Wisconsin, situated at 8333 Greenway Boulevard, Suite 240. Relief Mental Health, a leader in innovative mental health…

Read MoreRelief Mental Health Expands to Middleton, WI, Offering Advanced Treatments in the Madison Area

Dr. Howard McLeod Joins Cofactor Genomics Advisory Board as OncoPrism Test Launches in Partnered Hospitals

Cofactor Genomics, Inc., a clinical-stage company focused on bridging the precision medicine gap through RNA decoding, has announced the appointment of Dr. Howard McLeod, Pharm.D., FASCO, FCCP, to its Advisory Board. Dr. McLeod is a recognized global leader in precision…

Read MoreDr. Howard McLeod Joins Cofactor Genomics Advisory Board as OncoPrism Test Launches in Partnered Hospitals

Next Health Expands with Six New Proactive Healthcare & Longevity Centers in Sacramento, Reno, and Walnut Creek

Next Health, recognized as a leader in proactive healthcare, has announced a significant expansion into the Sacramento area, Walnut Creek, and Reno through an area development agreement. This move aligns with Next Health’s growth strategy of establishing thriving centers in…

Read MoreNext Health Expands with Six New Proactive Healthcare & Longevity Centers in Sacramento, Reno, and Walnut Creek

Movemedical Teams Up with Resurgens Technology to Enhance Medical Device Supply Chain Innovation

Movemedical, a leading enterprise software platform for medical device inventory management, has announced a strategic investment partnership with Resurgens Technology Partners. This collaboration will provide essential capital to support Movemedical’s ongoing growth and expansion, advancing its mission to unify the…

Read MoreMovemedical Teams Up with Resurgens Technology to Enhance Medical Device Supply Chain Innovation

Lucent Diagnostics Unveils Multi-Marker Blood Test for Early Alzheimer’s Detection

Lucent Diagnostics, a division of Quanterix Corporation (NASDAQ: QTRX), has launched LucentAD Complete, an innovative multi-marker blood test aimed at enhancing Alzheimer’s Disease (AD) detection across a wider patient population. Recent guidelines from the Alzheimer’s Association suggest using plasma p-Tau…

Read MoreLucent Diagnostics Unveils Multi-Marker Blood Test for Early Alzheimer’s Detection

Elixir Medical’s DynamX Bioadaptor Outperforms Drug-Eluting Stent in Acute Coronary Syndrome Patients

Elixir Medical, known for its innovative technologies in treating cardiovascular disease, has announced compelling late-breaking data showcasing the advantages of the DynamX® Coronary Bioadaptor System over the Resolute Onyx™ zotarolimus drug-eluting stent (DES) in reducing target lesion failure (TLF) among…

Read MoreElixir Medical’s DynamX Bioadaptor Outperforms Drug-Eluting Stent in Acute Coronary Syndrome Patients

Egnite Inc. Shows Survival Boost for Asymptomatic Aortic Stenosis Patients Post-AVR

Egnite, Inc., a leading cardiovascular digital health company, has announced significant findings from its research on the real-world effects of clinical presentation in patients with moderate or greater aortic stenosis (AS) undergoing aortic valve replacement (AVR). Presented by Dr. Philippe…

Read MoreEgnite Inc. Shows Survival Boost for Asymptomatic Aortic Stenosis Patients Post-AVR